2 completed, 2 terminated. 1 Phase 1, 1 Phase 2, 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Terminated 1 |
| Phase 3 | 1 | Completed 1 |
| Phase 4 | 1 | Terminated 1 |
Follow Rafa Laboratories: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Midazolam in Healthy Adults Midazolam, Seizalam - Status Epilepticus | Phase 1 | Completed | Rafa Laboratories | 40 | 2021-06-09 | 2022-03-17 |
| Hypericum vs Fluoxetine for Mild to Moderate Adolescent Depression hypericum, fluoxetine - Depression | Phase 4 | Terminated | Rafa Laboratories | 30 | 2009-01-01 | 2011-06-27 |
| Comparison of Delta-8-THC to Ondansetron in the Prevention of Acute Nausea From Moderately Emetogenic Chemotherapy inhaled delta-8-THC 300mcg or 600mcg per dose - Cancer | Phase 2 | Terminated | Rafa Laboratories | 6 | 2005-11-01 | 2020-12-23 |
| Treatment of Gastro-Intestinal and/or Hepatic Graft Versus Host Disease With Budesonide in Patients Following Peripheral Blood Stem Cell Transplantation Budesonide - Graft Vs Host Disease | Phase 3 | Completed | Rafa Laboratories | 24 | 2001-01-01 | 2005-08-29 |
Depression (1) · Graft vs Host Disease (1) · Nausea (1) · Neoplasms (1) · Status Epilepticus (1) · Vomiting (1)
Budesonide (1) · Fluoxetine (1) · Midazolam (1) · Ondansetron (1)
Israel (3) · United States (1)
Alan Apter, MD (1) · Michael Y Shapira, MD (1) · Nathan Cherny, MD (1)